MEDOVEX CORP's ticker is MDVX and the CUSIP is 58504H101. A total of 10 filers reported holding MEDOVEX CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $154,000 | +266.7% | 150,000 | +200.0% | 0.04% | +80.0% |
Q2 2017 | $42,000 | -44.7% | 50,000 | 0.0% | 0.02% | -46.8% |
Q1 2017 | $76,000 | +15.2% | 50,000 | 0.0% | 0.05% | +6.8% |
Q4 2016 | $66,000 | -10.8% | 50,000 | 0.0% | 0.04% | -12.0% |
Q3 2016 | $74,000 | +12.1% | 50,000 | 0.0% | 0.05% | +11.1% |
Q2 2016 | $66,000 | +26.9% | 50,000 | 0.0% | 0.04% | +25.0% |
Q1 2016 | $52,000 | – | 50,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MERIDIAN INVESTMENT COUNSEL INC. | 50,000 | $66,000 | 0.04% |
TWO SIGMA SECURITIES, LLC | 38,781 | $51,000 | 0.03% |
M Holdings Securities, Inc. | 12,000 | $16,000 | 0.01% |
Citadel Advisors | 14,795 | $19,000 | 0.00% |
Tower Research Capital LLC (TRC) | 794 | $1,000 | 0.00% |
DEUTSCHE BANK AG\ | 65 | $0 | 0.00% |
BlackRock Fund Advisors | 2,674 | $4,000 | 0.00% |
VANGUARD GROUP INC | 14,888 | $20,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
UBS Group AG | 2,302 | $3,000 | 0.00% |